Ultra-Early Evacuation of Intracerebral Spontaneous Hematomas

Česká verzia

Authors: M. Vaverka; J. Kozák; D. Šaňák; D. Krahulík; L. Hrabálek
Authors place of work: Neurochirurgická klinika LF UP a FN Olomouc
Published in the journal: Cesk Slov Neurol N 2013; 76/109(1): 56-62
Category: Original Paper

Summary

Introduction:
The thrombolysis project enables patients to reach emergency departments within the first hour after a cerebrovascular event that is in 20–35% caused by intracerebral hematoma (ICH). Early diagnosis of ICH thus allows for ultra-early evacuation.

Objective:
Open microsurgery via transylvian approach and precise coagulation of bleeding sources to minimize secondary bleeding with rapid and complete decompression all types of hematoma brings positive effect on secondary brain tissue injury (hypoperfusion, metabolic changes and intracranial hypertension). Ultra-early evacuation of ICH is based on the hypothesis that the undamaged brain tissue is temporarily able to compensate for the negative changes caused by the bleeding.

Methods:
Prospective study with 2.5 years of follow up of ICH patients with data collection and final evaluation at least 6 month after stroke. The inclusion criteria: spontaneous hypertonic putaminal ICH, MR or CT scan, volume ≥ 30 ml, GCS ≥ 8, the time to surgery ≤ 5–8 hrs., treatment in neurosurgical ICU with multimodality monitoring (with invasive ICP and P_BT0²).

Results:
Follow-up of 17 patients (F : M 2 : 15, age 60.6), mean time to surgery 3.8 hours, ICH volume of 73 ml (30–130 ml), mRS 3.5 and GOS 2.9 after six months. Six patients died and six reached favorable results. Volume was the most limiting factor; results were poor in the ≥ 100 ml group.

Conclusion:
The indication of surgery is still controversial. Open microsurgery is the method of choice in the ultra-early evacuation and coagulation of the primary source of bleeding is the prevention of rebleeding. Clinically significant independence is expected in patients with the initial volume of 30–80 ml and GCS ≥ 8 after stroke only.

Key words:
intracerebral hematoma – surgical treatment

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Zdroje

1. Beneš V. Mozkové krvácení hypertoniků: Chirurgické léčení. Praha: Avicenum 1983.

2. Smrčka V, Zicha J. Spontánní intracerebrální hematomy. Diagnostika, klinika, terapie. Brno: Masarykova univerzita 1994.

3. Kanno T, Sano H, Shinomiya Y, Katada K, Nagata J, Hoshino M et al. Role of surgery in hypertensive ICH. A comparative study of 305 nonsurgical and 154 surgical cases. J Neurosurg 1984; 61(6): 1091–1099.

4. Siddique MS, Fernandes HM, Wooldridge TD, Fenwick JD, Slomka P, Mendelow DJ. Reversible ischemia around intracerebral hemorrhage: SPECT study.J Neurosurg 2002; 96(4): 736–741.

5. Nilsson OG, Polito A, Säveland H, Ungerstedt U, Nordström CH. Are primary supratentorial intracerebral hemorrhages surrounded by a biochemical penumbra? A microdialysis study. Neurosurgery 2006; 59(3): 521–528.

6. Aronowski J, Zhao X. Molecular patophysiology of cerebral hemorrhage: secondary brain injury. Stroke 2011; 42(6): 1781–1786.

7. Andaluz N, Zuccarello M. Recent trends in the treatment of spontaneous intracerebral hemorrhage: analysis of a nationwide inpatient database. J Neurosurg 2009; 110(3): 404–410.

8. Morioka J, Fujii M, Kato S, Fujisawa H, Akimura T, Suzuki M et al. Japan Standard Stroke Registry Group (JSSR). Surgery for spontaneous ICH has greater remedial value than conservative therapy. Surg Neurol 2006; 65(1): 67–73.

9. Kaya RA, Türkmenoglu O, Ziyal IM, Dalkilic T, Sahin Y, Aydin Y. The effects on prognosis of surgical treatment of hypertensive putaminal hematomas through transsylvian transinsular approach. Surg Neurol 2003; 59(3): 176–183.

10. Pantazis G, Tsitsopoulos P, Mihas C, Katsiva V, Stavrianos V, Zymaris S. Early surgical treatment vs conservative management for spontaneous ICH: a prospective randomized study. Surg Neurol 2006; 66(5): 492–502.

11. Boshert S. Spot sign predict intracerebral hemorrhage growth. Family practice news digital network. Available from: http://www.medconnect.com.au/.

12. Wang YF, Wu JS, Mao Y, Chen XC, Zhou LF, Zhang Y. The optimal time-window for surgical treatment of spontaneous intracerebral hemorrhage: results of prospective randomized controlled trial of 500 case. Acta Neurochir Suppl 2008; 105: 141–145.

13. Kaneko M, Tanaka K, Shimada T, Sato K, Uemura K. Long-term evaluation of ultra-early operation for hypertensive ICH in 100 cases. J Neurosurg 1983; 58(6): 838–842.

14. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT at al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral hematomas in the International Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005; 365(9457): 387–397.

15. Oiu TM, Zhang Y, Wu JS. Preliminary application of pyramidal tractography in evaluating prognosis of patients with hypertensive intracerebral hemorrhage. Acta Neurochir Suppl 2008; 105: 165–167.

16. Adeoyne O, Woo D, Haverbusch M, Sekar P, Moomaw CJ, Broderick J et al. Surgical management and case-fatality rates of ICH in 1988 and 2005. Neurosurgery 2008; 63(6): 1113–1117.

17. Chen XG, Yang H, Czhering Z. The comparative study of the total medical and surgical treatment of hypertensive haemorrhage. Acta Academica Medicinae Shangai 1990; 19: 234–240.

18. Chen XC, WU JS, Zhou XP, Wang YF, Mao Y, Zhang Y et al. The randomized multicentric prospective controlled trial in the standardized treatment of surgical therapeutic outcomes with conservative therapy. Chin J Clin Neurosci 2001; 9: 365–368.

19. Hänggi D, Steiger HJ. Spontaneous intracerebral haemorrhage in adults: a literature overview. Acta Neurochir 2008; 150(4): 371–379.

20. Hosseini HC, Leguirinel C, Hariz M, Melon E, Palfi S, Beck P et al. Stereotactic aspiration of deep intracerebral hematomas under CT control: a multicentric prospective randomized trial.12^th European stroke conference 2003; Spain, Valencia.

21. Auer LM, Deinsberger W, Niederkorn K, Gell G, Kleinert R, Schneider G et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg 1989; 70(4): 530–535.

22. Zuccarello M. Intracerebral hemorrhage: surgical trial overview. Neurotrauma and vascular neurosurgery. International proceedings. Bologna: Medimond 2011: 11–16.

23. Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr et al. Guidelines for management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41(9): 2108–2129.

24. Hrabálek L, Houdek M, Dvořák P, Heřman M. CT řízená stereotaktická léčba intracerebrálních hematomů s použitím urokinasy. Cesk Slov Neurol N 1996; 59/92(6): 319–325.

25. Tan SH, NG PY, Yeo TT, Wong SH, Ong PL, Venketasubramanian N. Hypertensive basal ganglia hemorrhage: a prospective study comparing surgical and nonsurgical management. Surg Neurol 2001; 56(5): 287–293.

26. McKissock W, Richardson A, Taylor J. Primary intracerebral haemorrhage. A controlled trail of surgical and conservative treatment in 180 unselected cases. Lancet 1961; 2: 221–226.

27. Morgenstern LB, Frankowski RF, Shedden P, Pasteur W, Grotta JC. Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial. Neurology 1998; 51(5): 1359–1363.

28. Zuccarello M, Brott T, Derex L, Kothari R, Sauerbeck T, Tew J et al. Early surgical treatment for supratentorial intracerebral hemorrhage: a randomized feasibility study. Stroke 1999; 30(9): 1833–1839.

29. Juvela S, Heiskanen O, Poranen A, Valtonen S, Kuurne T, Kaste M at al. The treatment of spontaneous intracerebral hemorrhage: a prospective randomized trial of surgical and conservative treatment. J Neurosurg 1989; 70(5): 755–758.

30. Batjer HH, Reisch JS, Allen BC, Plaizier LJ, Su CJ. Failure of surgery to improve outcome in hypertensive putaminal hemorrhage. A prospective randomized trial. Arch Neurol 1990; 47(10): 1103–1106.

31. Hattori N, Katayama Y, Maya Y, Gatherer A. Impact of stereotactic hematoma evacuation on activities of daily living during the chronic period following spontaneous putaminal hemorrhage: a prospective randomized study. J Neurosurg 2004; 101(3): 414–420.

32. Wang WZ, Jiang B, Liu HM, Li D, Lu CZ, Zhao YD et al. Minimally invasive craniopuncture therapy vs conservative treatment for spontaneous intracerebral hemorrhage: results from a randomized clinical trial in China. Int J Stroke 2009; 4(1): 11–16.

33. Teernstra OP, Evers SM, Lodder J, Leffers P, Franke CL, Blaauw G at al. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 2003; 34(4): 968–974.

34. Kaya A, Türkmenoglu O, Ziyal IM, Dalkilic T, Sahin Y, Aydin Y. The effects on prognosis of surgical treatment of hypertensive putaminal hematomas through transsylvian transinsular approach. Surg Neurol 2003; 59(3): 176–183.

35. Sorimachi T, Fujii Y, Morita K, Tanaka R. Predictors of hematoma enlargement in patients with ICH treated with rapid administration of antifibrinolytic agents and strict blood pressure control. J Neurosurg 2007; 106(2): 250–254.